SBC Medical Group (NASDAQ:SBC) Sets New 52-Week High – Should You Buy?

SBC Medical Group Holdings Incorporated (NASDAQ:SBC)’s share price hit a new 52-week high during mid-day trading on Thursday. The stock traded as high as $5.61 and last traded at $5.6040, with a volume of 61,660 shares. The stock had previously closed at $5.54.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Wall Street Zen raised shares of SBC Medical Group from a “buy” rating to a “strong-buy” rating in a report on Monday, October 5th. BTIG Research reaffirmed a “buy” rating and set a $8.00 price target on shares of SBC Medical Group in a research report on Thursday, August 13th. Finally, Weiss Ratings upgraded SBC Medical Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 9th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $8.50.

SBC Medical Group Trading Down 7.2%

The company has a current ratio of 3.31, a quick ratio of 3.27 and a debt-to-equity ratio of 0.09. The company has a fifty day moving average of $4.71 and a 200-day moving average of $3.77. The company has a market capitalization of $543.05 million, a price-to-earnings ratio of 11.23, a PEG ratio of 2.56 and a beta of 0.56.

SBC Medical Group (NASDAQ:SBC) last posted its quarterly earnings data on Thursday, August 13th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.02). SBC Medical Group had a net margin of 27.99% and a return on equity of 18.47%. The firm had revenue of $49.19 million during the quarter, compared to analyst estimates of $45.37 million. As a group, equities research analysts anticipate that SBC Medical Group Holdings Incorporated will post 0.44 earnings per share for the current fiscal year.

Institutional Investors Weigh In On SBC Medical Group

A number of hedge funds have recently modified their holdings of SBC. BlackRock Inc. acquired a new stake in SBC Medical Group in the 2nd quarter valued at about $2,846,000. Citadel Advisors LLC purchased a new stake in shares of SBC Medical Group in the second quarter valued at approximately $446,000. Segall Bryant & Hamill LLC purchased a new stake in shares of SBC Medical Group in the first quarter valued at approximately $340,000. State Street Corp increased its holdings in shares of SBC Medical Group by 59.7% in the second quarter. State Street Corp now owns 49,239 shares of the company’s stock valued at $152,000 after purchasing an additional 18,400 shares during the last quarter. Finally, Williams & Novak Wealth Management LLC increased its holdings in shares of SBC Medical Group by 40.9% in the third quarter. Williams & Novak Wealth Management LLC now owns 26,330 shares of the company’s stock valued at $130,000 after purchasing an additional 7,644 shares during the last quarter. 60.82% of the stock is currently owned by institutional investors and hedge funds.

SBC Medical Group Company Profile

SBC Medical Group Holdings Incorporated is a Japan-based healthcare services company focused on supporting aesthetic medicine and related medical institutions. Through its group companies, the business provides operational and management support designed to help clinics deliver cosmetic surgery, dermatology, and other elective medical services.

The company’s services include clinic management consulting, marketing, staff recruitment and training, procurement, information technology, and administrative support.